← All funded startups

May 7, 2026

WittGen Biotechnologies

WittGen Biotechnologies utilizes a single-cell RNA sequencing data analysis and testing to overcome the heterogeneity of cancer.

Round
Seed
Amount raised
Lead investor
CancerX Startup Accelerator
Industry
Biotechnology
Headquarters
Berkeley, United States
Employees
1-10

Other investors

  • Digital Healthcare Partners
  • Nautilus
  • Plug and Play

Source: Crunchbase snapshot 2026-05-15